BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31806655)

  • 61. Performance Status in Cancer: Not Broken, But Time for an Upgrade?
    Scott JM; Stene G; Edvardsen E; Jones LW
    J Clin Oncol; 2020 Sep; 38(25):2824-2829. PubMed ID: 32584631
    [No Abstract]   [Full Text] [Related]  

  • 62. Is It Time to Integrate Frailty Assessment in Onconephrology?
    Wu HHL; Chinnadurai R; Walker RJ; Tennankore KK
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Absorbable Artificial Dura Versus Nonabsorbable Artificial Dura in Decompressive Craniectomy for Severe Traumatic Brain Injury: A Retrospective Cohort Study in Two Centers.
    Zhang ZD; Zhao LY; Liu YR; Zhang JY; Xie SH; Lin YQ; Tang ZN; Fang HY; Yang Y; Li SZ; Liu JX; Sheng HS
    Front Surg; 2022; 9():877038. PubMed ID: 35865039
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
    Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
    Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of Outcome and Quality of Life Between Thulium Laser (Vela
    Chen YT; Hou CP; Juang HH; Lin YH; Yang PS; Chang PL; Chen CL; Weng SC; Tsui KH
    Ther Clin Risk Manag; 2022; 18():145-154. PubMed ID: 35237038
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia.
    Abdelmalak R; Lythgoe MP; Evans J; Flynn M; Waters J; Webb A; Pinato DJ; Sharma R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439386
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Palliative Performance Scale: cross cultural adaptation and psychometric validation for Polish hospice setting.
    Dzierżanowski T; Gradalski T; Kozlowski M
    BMC Palliat Care; 2020 Apr; 19(1):52. PubMed ID: 32321494
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.
    Friedlaender A; Banna GL; Buffoni L; Addeo A
    Curr Oncol Rep; 2019 Nov; 21(12):107. PubMed ID: 31768759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inter-rater reliability in performance status assessment between clinicians and patients: a systematic review and meta-analysis.
    Chow R; Zimmermann C; Bruera E; Temel J; Im J; Lock M
    BMJ Support Palliat Care; 2020 Jun; 10(2):129-135. PubMed ID: 31806655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis.
    Chow R; Bruera E; Temel JS; Krishnan M; Im J; Lock M
    Support Care Cancer; 2020 May; 28(5):2071-2078. PubMed ID: 31900613
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inter-rater reliability in performance status assessment among health care professionals: a systematic review.
    Chow R; Chiu N; Bruera E; Krishnan M; Chiu L; Lam H; DeAngelis C; Pulenzas N; Vuong S; Chow E
    Ann Palliat Med; 2016 Apr; 5(2):83-92. PubMed ID: 27121736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.
    Zimmermann C; Burman D; Bandukwala S; Seccareccia D; Kaya E; Bryson J; Rodin G; Lo C
    Support Care Cancer; 2010 May; 18(5):609-16. PubMed ID: 19629537
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Functionality Assessment Flowchart (FAF): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.
    Paiva CE; Siquelli FA; Santos HA; Costa MM; Massaro DR; Lacerda DC; Nunes JS; de Pádua Souza C; Paiva BS
    BMC Cancer; 2015 Jul; 15():501. PubMed ID: 26142726
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals.
    Azam F; Latif MF; Farooq A; Tirmazy SH; AlShahrani S; Bashir S; Bukhari N
    Case Rep Oncol; 2019; 12(3):728-736. PubMed ID: 31616281
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.